1. Home
  2. RVMD vs WBA Comparison

RVMD vs WBA Comparison

Compare RVMD & WBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • WBA
  • Stock Information
  • Founded
  • RVMD 2014
  • WBA 1901
  • Country
  • RVMD United States
  • WBA United States
  • Employees
  • RVMD N/A
  • WBA N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • WBA Retail-Drug Stores and Proprietary Stores
  • Sector
  • RVMD Health Care
  • WBA Consumer Staples
  • Exchange
  • RVMD Nasdaq
  • WBA Nasdaq
  • Market Cap
  • RVMD 8.7B
  • WBA 9.4B
  • IPO Year
  • RVMD 2020
  • WBA N/A
  • Fundamental
  • Price
  • RVMD $44.39
  • WBA $9.19
  • Analyst Decision
  • RVMD Strong Buy
  • WBA Hold
  • Analyst Count
  • RVMD 12
  • WBA 14
  • Target Price
  • RVMD $64.67
  • WBA $12.58
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • WBA 26.0M
  • Earning Date
  • RVMD 11-06-2024
  • WBA 01-09-2025
  • Dividend Yield
  • RVMD N/A
  • WBA 10.88%
  • EPS Growth
  • RVMD N/A
  • WBA N/A
  • EPS
  • RVMD N/A
  • WBA N/A
  • Revenue
  • RVMD $742,000.00
  • WBA $147,658,000,000.00
  • Revenue This Year
  • RVMD N/A
  • WBA $2.05
  • Revenue Next Year
  • RVMD $1,855.42
  • WBA $1.60
  • P/E Ratio
  • RVMD N/A
  • WBA N/A
  • Revenue Growth
  • RVMD N/A
  • WBA 6.17
  • 52 Week Low
  • RVMD $25.93
  • WBA $8.08
  • 52 Week High
  • RVMD $62.40
  • WBA $27.05
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 34.18
  • WBA 47.85
  • Support Level
  • RVMD $42.53
  • WBA $9.54
  • Resistance Level
  • RVMD $44.22
  • WBA $10.39
  • Average True Range (ATR)
  • RVMD 1.59
  • WBA 0.68
  • MACD
  • RVMD -0.27
  • WBA -0.03
  • Stochastic Oscillator
  • RVMD 28.46
  • WBA 28.47

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About WBA Walgreens Boots Alliance Inc.

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Share on Social Networks: